This company listing is no longer active
Wellfully (WFL) Stock Overview
Wellfully Limited, together with its subsidiaries, focuses on the development and commercialization of Dermaportation and ETP transdermal drug delivery technologies. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
WFL Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Join community and earn perks
Wellfully Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.004 |
| 52 Week High | AU$0.022 |
| 52 Week Low | AU$0.002 |
| Beta | -0.91 |
| 1 Month Change | 0% |
| 3 Month Change | 33.33% |
| 1 Year Change | -83.33% |
| 3 Year Change | -97.84% |
| 5 Year Change | -98.95% |
| Change since IPO | -99.78% |
Recent News & Updates
Recent updates
Shareholder Returns
| WFL | AU Pharmaceuticals | AU Market | |
|---|---|---|---|
| 7D | 0% | -1.5% | -3.0% |
| 1Y | -83.3% | -7.1% | -2.6% |
Return vs Industry: WFL underperformed the Australian Pharmaceuticals industry which returned 10.2% over the past year.
Return vs Market: WFL underperformed the Australian Market which returned -0.5% over the past year.
Price Volatility
| WFL volatility | |
|---|---|
| WFL Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 10.7% |
| Market Average Movement | 9.6% |
| 10% most volatile stocks in AU Market | 16.6% |
| 10% least volatile stocks in AU Market | 3.9% |
Stable Share Price: WFL has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine WFL's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | n/a | Paul Peros | www.wellfully.net |
Wellfully Limited, together with its subsidiaries, focuses on the development and commercialization of Dermaportation and ETP transdermal drug delivery technologies. It operates in two segments, Dermaportation Drug Delivery Technology and Devices. The company is also involved in the industrialization and supply-chain support for its existing product ranges; and sale and marketing of its own brands REDUIT and SWISSWELL, as well as third-party collaborations.
Wellfully Limited Fundamentals Summary
| WFL fundamental statistics | |
|---|---|
| Market cap | AU$1.48m |
| Earnings (TTM) | -AU$7.80m |
| Revenue (TTM) | AU$1.66m |
Is WFL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| WFL income statement (TTM) | |
|---|---|
| Revenue | AU$1.66m |
| Cost of Revenue | AU$1.86m |
| Gross Profit | -AU$200.41k |
| Other Expenses | AU$7.60m |
| Earnings | -AU$7.80m |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.016 |
| Gross Margin | -12.05% |
| Net Profit Margin | -469.00% |
| Debt/Equity Ratio | -98.7% |
How did WFL perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/10/22 14:03 |
| End of Day Share Price | 2023/07/25 00:00 |
| Earnings | 2022/12/31 |
| Annual Earnings | 2022/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Wellfully Limited is covered by 0 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.